TGCB — what changed in the latest 10-Q
A section-by-section comparison of TGCB's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2024-05-17 vs the prior 10-Q · 2024-03-19
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +4 | −4 | ~16 | 25 |
| Market risk (Item 3) | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Controls & procedures | Text added/removed | 0 | 0 | ~6 | 5 |
| Legal proceedings | No paragraph-level changes | 0 | 0 | 0 | 2 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Not shown (absent or not faithfully extractable): Risk factors, Other information
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2024-05-17
General & administration decreased by $1,525,970 to $652,640 for the three months ended March 31, 2024, compared to $2,178,610 for the three months ended March 31, 2023. The majority of the decrease was due to planned cost reductions. The majority of the decrease was due to planned cost reductions.
We incurred a net loss of $1,062,163 for the three months ended March 31, 2024, compared to a net loss of $4,854,357 for the three months ended March 31, 2023. The increase in the loss was mostly due to financing fees relating to note extensions.
General & administration decreased by $1,393,584 to $2,469,866 for the nine months ended March 31, 2024, as compared to $3,863,450 for the nine months ended March 31, 2023. The majority of the decrease was due to planned cost reductions.
We incurred a net operating loss of $2,622,343 for the nine months ended March 31, 2024, compared to a net operating loss of $4,701,310 for the nine months ended March 31, 2023.
Text removed vs the prior filing · source: 10-Q · 2024-03-19
General & administration increased by $139,913 to $978,960 for the three months ended December 31, 2023, compared to $839,047 for the three months ended December 31, 2022. The majority of the increase was due to the Company transitioning from development to commercialization.
We incurred a net loss of $2,217,137 for the three months ended December 31, 2023, compared to a net loss of $1,327,148 for the three months ended December 31, 2022. The increase in the loss was mostly due to financing fees relating to note extensions.
We incurred a net operating loss of $1,940,788 for the six months ended December 31, 2023, compared to a net operating loss of $2,108,927 for the six months ended December 31, 2022.
We incurred a net loss of $6,327,151 for the six months ended December 31, 2023, compared to a net loss of $2,645,278 for the six months ended December 31, 2022. The increase in the loss was mostly due to financing fees relating to note extensions.
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice